Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan
· Delayed Price · Currency is TWD 15.05
-0.10 (-0.66%)
Apr 29, 2026, 1:57 PM CST
Original BioMedicals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 133.85 | 151.45 | 228.68 | 13.98 | 8.46 | Upgrade
|
| Short-Term Investments | 9.99 | 89.74 | 99.8 | 34.93 | 74.85 | Upgrade
|
| Cash & Short-Term Investments | 143.84 | 241.19 | 328.48 | 48.91 | 83.31 | Upgrade
|
| Cash Growth | -40.36% | -26.57% | 571.60% | -41.29% | 928.77% | Upgrade
|
| Other Receivables | 13.99 | 13.51 | 11.55 | 9.99 | 9.59 | Upgrade
|
| Receivables | 13.99 | 13.51 | 11.55 | 9.99 | 9.59 | Upgrade
|
| Other Current Assets | 6.2 | 1.61 | 1.37 | 0.89 | 1.55 | Upgrade
|
| Total Current Assets | 164.03 | 256.31 | 341.4 | 59.79 | 94.46 | Upgrade
|
| Property, Plant & Equipment | 18.75 | 21.9 | 28.08 | 36.19 | 41.03 | Upgrade
|
| Other Long-Term Assets | 1.16 | 1.16 | 1.16 | 2.05 | 1.88 | Upgrade
|
| Total Assets | 183.94 | 279.37 | 370.63 | 98.04 | 137.37 | Upgrade
|
| Accrued Expenses | 10.56 | 8.56 | 7.48 | 4.29 | 3.93 | Upgrade
|
| Current Portion of Leases | 4.17 | 4.52 | 4.26 | 3.62 | 3.14 | Upgrade
|
| Other Current Liabilities | 2.12 | 1.35 | 18.12 | 2.46 | 1.44 | Upgrade
|
| Total Current Liabilities | 16.84 | 14.43 | 29.86 | 10.36 | 8.52 | Upgrade
|
| Long-Term Leases | 7.03 | 7.47 | 11.98 | 16.27 | 17.52 | Upgrade
|
| Other Long-Term Liabilities | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | Upgrade
|
| Total Liabilities | 26.1 | 24.12 | 44.07 | 28.86 | 28.26 | Upgrade
|
| Common Stock | 665.89 | 659.92 | 655.5 | 470.5 | 470.5 | Upgrade
|
| Additional Paid-In Capital | 1.06 | 384.17 | 384.9 | 252.85 | 252.51 | Upgrade
|
| Retained Earnings | -509.12 | -788.83 | -713.84 | -654.18 | -613.9 | Upgrade
|
| Shareholders' Equity | 157.84 | 255.25 | 326.57 | 69.17 | 109.11 | Upgrade
|
| Total Liabilities & Equity | 183.94 | 279.37 | 370.63 | 98.04 | 137.37 | Upgrade
|
| Total Debt | 11.19 | 11.98 | 16.24 | 19.89 | 20.66 | Upgrade
|
| Net Cash (Debt) | 132.65 | 229.21 | 312.24 | 29.02 | 62.65 | Upgrade
|
| Net Cash Growth | -42.13% | -26.59% | 976.08% | -53.69% | - | Upgrade
|
| Net Cash Per Share | 2.00 | 3.47 | 6.33 | 0.62 | 1.51 | Upgrade
|
| Filing Date Shares Outstanding | 66.59 | 65.99 | 65.55 | 47.05 | 47.05 | Upgrade
|
| Total Common Shares Outstanding | 66.59 | 65.99 | 65.55 | 47.05 | 47.05 | Upgrade
|
| Working Capital | 147.18 | 241.88 | 311.54 | 49.43 | 85.94 | Upgrade
|
| Book Value Per Share | 2.37 | 3.87 | 4.98 | 1.47 | 2.32 | Upgrade
|
| Tangible Book Value | 157.84 | 255.25 | 326.57 | 69.17 | 109.11 | Upgrade
|
| Tangible Book Value Per Share | 2.37 | 3.87 | 4.98 | 1.47 | 2.32 | Upgrade
|
| Machinery | 4.67 | 44.92 | 47.15 | 46.96 | 46.84 | Upgrade
|
| Leasehold Improvements | 36.85 | 36.85 | 36.85 | 36.73 | 36.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.